TCIM
IART icon

TIAA CREF Investment Management’s Integra LifeSciences IART Stock Holding History

TIAA CREF Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$6.84M Sell
122,689
-41,025
-25% -$2.09M ﹤0.01% 1256
2018
Q4 		$7.38M Buy
163,714
+51,931
+46% +$2.85M 0.01% 1124
2018
Q3 		$7.36M Sell
111,783
-52,535
-32% -$3.26M ﹤0.01% 1311
2018
Q2 		$10.6M Buy
164,318
+10,914
+7% +$676K 0.01% 1123
2018
Q1 		$8.49M Sell
153,404
-1,047
-0.7% -$54.9K 0.01% 1214
2017
Q4 		$7.39M Sell
154,451
-11,758
-7% -$576K ﹤0.01% 1352
2017
Q3 		$8.39M Sell
166,209
-448
-0.3% -$23K 0.01% 1263
2017
Q2 		$9.08M Sell
166,657
-25,008
-13% -$1.19M 0.01% 1205
2017
Q1 		$8.07M Sell
191,665
-9,651
-5% -$412K 0.01% 1263
2016
Q4 		$8.63M Buy
201,316
+12,256
+6% +$498K 0.01% 1215
2016
Q3 		$7.8K Sell
189,060
-1,918
-1% -$80.4K ﹤0.01% 1283
2016
Q2 		$7.62M Sell
190,978
-61,222
-24% -$2.2M 0.01% 1236
2016
Q1 		$8.49M Sell
252,200
-74,004
-23% -$2.31M 0.01% 1148
2015
Q4 		$11.1M Sell
326,204
-11,332
-3% -$354K 0.01% 1012
2015
Q3 		$10.1M Buy
337,536
+4,938
+1% +$154K 0.01% 1041
2015
Q2 		$9.16M Buy
332,598
+95,016
+40% +$2.53M 0.01% 1215
2015
Q1 		$5.99M Buy
237,582
+3,663
+2% +$86.6K ﹤0.01% 1501
2014
Q4 		$5.18M Sell
233,919
-24,010
-9% -$487K ﹤0.01% 1610
2014
Q3 		$5.23M Sell
257,929
-531
-0.2% -$10.6K ﹤0.01% 1583
2014
Q2 		$4.97M Buy
258,460
+8,391
+3% +$156K ﹤0.01% 1703
2014
Q1 		$4.7M Sell
250,069
-3,816
-2% -$73.6K ﹤0.01% 1661
2013
Q4 		$4.95M Sell
253,885
-6,826
-3% -$125K ﹤0.01% 1643
2013
Q3 		$4.29M Sell
260,711
-5,338
-2% -$85.7K ﹤0.01% 1685
2013
Q2 		$3.98M Buy
+266,049
New +$3.9M ﹤0.01% 1694

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's IART Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Integra LifeSciences (IART) stake by 25% in Q1 2019, selling an estimated $2.09M and leaving 122,689 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

TIAA CREF Investment Management first reported a position in IART in Q2 2013 and has held it in 24 quarters since. The position peaked at $11.1M in Q4 2015. 259 funds tracked by Wall St. Rank hold IART as of Q1 2019.

  • TIAA CREF Investment Management held 122,689 shares of Integra LifeSciences worth $6.84M as of Q1 2019.
  • TIAA CREF Investment Management sold 41,025 Integra LifeSciences shares in Q1 2019, an estimated $2.09M.
  • Integra LifeSciences made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1256 holding.
  • TIAA CREF Investment Management first reported a position in Integra LifeSciences in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Integra LifeSciences position peaked at $11.1M in Q4 2015.
  • 259 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.